Search for content, post, videos

Latest news

Business

Medivir in license agreement
Medivir in license agreement

Medivir and Ascletis announce that Ascletis has licensed the exclusive rights to develop, manufacture and commercialize Medivir’s nucleotide polymerase inhibitor for hepatitis C, MIV-802 (Ascletis code: ASC21), in Greater China. Under

In Focus – Oncology

Research

New Innovation and Design

The European Inventor Award 2017
The European Inventor Award 2017

Exceptional inventors was honored at the European Inventor Award 2017 in Venice, and several of the innovations are in the life science area. Outstanding inventors from twelve countries took centre

Clinical Trials

Drug Development

Careers – On A New Job


View our latest newsletter